Related Experiment Videos

Effect of high dose intravenous pulse dexamethasone on lymphocyte phenotypes

A N Malaviya1, R Malaviya, R R Singh

  • 1Department of Medicine, All India Institute of Medical Sciences, New Delhi.

Insights

High-dose dexamethasone significantly reduced CD3 and CD4 lymphocyte counts in collagen disease patients. Lymphocyte levels returned to normal within seven days, showing a transient impact.

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Collagen diseases encompass a range of autoimmune disorders.
  • Corticosteroids, like dexamethasone, are commonly used to manage inflammation in these conditions.
  • Understanding the immunomodulatory effects of high-dose dexamethasone on lymphocyte subsets is crucial.

Purpose of the Study:

  • To investigate the impact of a high-dose intravenous pulse of dexamethasone on lymphocyte phenotypes in patients with collagen diseases.
  • To quantify changes in CD3, CD4, CD8, and B cell populations over time following dexamethasone administration.

Main Methods:

  • Lymphocyte phenotypes were enumerated using flow cytometry.
  • Ten patients diagnosed with collagen diseases were included in the study.
  • Blood samples were collected at baseline (0 h) and at 4 h, 24 h, and 7 days post-dexamethasone infusion.

Main Results:

  • A significant decrease in CD3 and CD4 T-lymphocyte counts was observed at 4 hours post-dexamethasone.
  • CD8 T-cell counts showed a transient decrease at 4 hours.
  • Lymphocyte populations, particularly CD3 and CD4 cells, demonstrated partial recovery by 24 hours and complete normalization by 7 days.
  • No significant alterations were noted in B cell counts.

Conclusions:

  • High-dose intravenous pulse dexamethasone induces a temporary but significant reduction in circulating CD3 and CD4 T-cells in patients with collagen diseases.
  • The observed lymphopenia is transient, with lymphocyte counts returning to baseline levels within a week.
  • These findings highlight the potent but reversible immunomodulatory effects of high-dose dexamethasone on T-cell populations.

Related Concept Videos